Grove Collaborative Holdings, Inc.

As of August 11, 2022, Grove Collaborative Holdings, Inc. is considered overvalued and risky, with poor financial ratios indicating distress, including a Price to Book Value of 4.05 and negative earnings, while its performance lags behind peers like Olaplex and Nu Skin, evidenced by a year-to-date decline of 23.02%.

As of April 30, 2024, the market trend is mildly bearish, indicated by bearish signals from the weekly MACD and KST, while the monthly Dow Theory shows a mildly bullish trend, suggesting limited upward momentum.

Grove Collaborative Holdings, Inc. is a micro-cap company in the FMCG industry, reporting net sales of $44 million and a net loss of $4 million as of March 2025. Key metrics include a market cap of $44.68 million and a return on equity of -205.19%.

As of Jun 18, Grove Collaborative Holdings, Inc. has a market capitalization of 44.68 million, with net sales of 193.43 million and a net profit of -27.58 million over the latest four quarters. As of Dec'24, the company reported shareholder's funds of 16.22 million and total assets of 65.01 million.